Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Raaxo takes shape after pivot from Aphrodite Bra Co’s body scan concept
Despite its use of body-mapping technology, Aphrodite Bra Company wasn’t the right fit for customers’ needs, said Carlanda McKinney, founder of the newly rebooted custom intimates company Raaxo. “Aphrodite had been stuck in the starting-up space,” she said. “We’d never really gotten enough sales or enough traction to say, ‘We’re launched,’ or, ‘We’re in business.’…
Serial entrepreneur leverages past success for Bridge Space coworking project
Bridge Space will be more than a coworking office, Ben Rao said. He hopes it will be the heart of Lee’s Summit’s blossoming entrepreneurial ecosystem. “My No. 1 goal is to accelerate entrepreneurs’ success,” said Rao, Bridge Space founder and a serial entrepreneur himself. “It’s an opportunity for me to build something that would make…
KC mom’s humble entrepreneurial journey draws on healing power of creativity
Huddled in her parents’ basement, between the cribs of her crying twin babies, Keliah Smith began to draw. She was unemployed and feeling emotionally drained. The relationship with her children’s father had soured. Her escape: the stylus and smartphone in her hands. The Kansas City mother drew what she didn’t see in the mirror, she…
Harvard University recognizes KCMO digital inclusion map
Kansas City’s geographic work to illustrate the area’s digital divide earned high praise from a prestigious university. Harvard University recently highlighted the City of Kansas City, Missouri’s Digital Inclusion map, a tool that — at a block-by-block scale — detail residents’ access to internet connectivity overlaid with poverty levels. “This visualization was chosen as Harvard’s…